Abstract
The AKT1 gene is of supreme importance in cell signaling and human cancer. In the present study, we aim to understand the phenotype variations that were believed to have the highest impact in AKT1 gene by different computational approaches. The analysis was initiated with SIFT tool followed by PolyPhen 2.0, I-Mutant 2.0, and SNPs&GO tools with the aid of 22 nonsynonymous (nsSNPs) retrieved from dbSNP. A total of five AKT1 variants such as E17K, E17S, E319G, L357P, and P388T are found to exert deleterious effects on the protein structure and function. Furthermore, the molecular docking study indicates the lesser binding affinity of inhibitor with the mutant structure than the native type. In addition, root mean square deviation and hydrogen bond details were also analyzed in the 10 ns molecular dynamics simulation study. These computational evidences suggested that E17K, E17S, E319G, L357P, and P388T variants of AKT1 could destabilize the protein networks, thus causing functional deviations of protein to some extent. Moreover, the findings strongly indicate that screening for AKT1, E17K, E17S, E319G, L357P, and P388T variants may be useful for disease molecular diagnosis and also to design the potential AKT inhibitors.
Similar content being viewed by others
References
Staal, S. P. (1987). Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America, 84, 5034–5037.
Vanhaesebroeck, B., & Alessi, D. R. (2000). The PI3K-PDK1 connection: More than just a road to PKB. The Biochemical Journal, 346, 561–576.
Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. (1998). Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. The Journal of biological chemistry, 273, 29864–29872.
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 399, 601–605.
Khwaja, A. (1999). Akt is more than just a Bad kinase. Nature, 401, 33–34.
Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature, 401, 82–85.
Mende, I., Malstrom, S., Tsichlis, P. N., Vogt, P. K., & Aoki, M. (2001). Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene, 20, 4419–4423.
Wei, L., Yang, Y., & Yu, Q. (2001). Tyrosine kinase-dependent, phosphatidylinositol 30-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis. Cancer Research, 61, 2439–2444.
Testa, J. R., & Bellacosa, A. (2001). AKT plays a central role in tumorigenesis. Proceedings of the National Academic Sciences of the United States of America, 98, 10983–10985.
Altomare, D. A., & Testa, J. R. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene, 24, 7455–7764.
Sun, M., Wang, G., Paciga, J. E., Feldman, R. I., Yuan, Z. Q., Ma, X. L., et al. (2001). AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. The American Journal of Pathology, 159, 431–437.
West, K. A., Castillo, S. S., & Dennis, P. A. (2002). Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resistance Updates, 5, 234–248.
Carpten, J. D., Faber, A. L., Horn, C., Donoho, G. P., Briggs, S. L., Robbins, C. M., et al. (2007). A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature, 448, 439–444.
Malanga, D., Scrima, M., De Marco, C., Fabiani, F., De Rosa, N., De Gisi, S., et al. (2008). Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle, 7, 665–669.
Lindsley, C. W. (2010). The Akt/PKB family of protein kinases: A review of small molecule inhibitors and progress towards target validation: A 2009 update. Current Topics in Medicinal Chemistry, 10, 458–477.
Rajasekaran, R., Sudandiradoss, C., Doss, C. G., & Sethumadhavan, R. (2007). Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics, 90, 447–452.
Rajasekaran, R., Priya Doss, C. G., Sudandiradoss, C., Ramanathan, K., & Sethumadhavan, R. (2008). In silico analysis of structural and functional consequences in p16INK4A by deleterious nsSNPs associated CDKN2A gene in malignant melanoma. Biochimie, 90, 1523–1529.
Madumathi, M., & Shanthi, V. (2012). Prediction of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) of GALC gene by computational method. International Journal of Pharmacy and Pharmaceutical Sciences, 3, 384387.
Rajasekaran, R., & Sethumadhavan, R. (2010). Exploring the cause of drug resistance by the detrimental missense mutations in KIT receptor: Computational approach. Amino Acids, 39, 651–660.
Sreevishnupriya, K., Chandrasekaran, P., Senthilkumar, A., Sethumadhavan, R., Shanthi, V., Daisy, P., et al. (2012). Computational analysis of deleterious missense mutations in aspartoacylase that cause Canavan’s disease. Science China Life sciences, 55, 1109–1119.
Feldman, J., Snyder, K. A., Ticoll, A., Pintilie, G., & Hogue, C. W. (2006). A complete small molecule dataset from the protein data bank. FEBS Letters, 580, 1649–1653.
Cavallo, A., & Martin, A. C. (2005). Mapping SNPs to protein sequence and structure data. Bioinformatics, 8, 1443–1450.
Hess, B., Kutzner, C., Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435–447.
Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701–1718.
Ng, P. C., & Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research, 31, 3812–3814.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., et al. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7, 248–249.
Capriotti, E., Fariselli, P., & Casadio, R. (2005). I Mutant 2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Research, 2005(33), 306–310.
Calabrese, R., Capriotti, E., Fariselli, P., Martelli, P. L., & Casadio, R. (2009). Functional annotations improve the predictive score of human disease-related mutations in proteins. Human Mutation, 30, 1237–1244.
Bava, K. A., Gromiha, M. M., Uedaira, H., et al. (2004). ProTherm, version 4.0: Thermodynamic database for proteins and mutants. Nucleic Acids Research, 32, 120–121.
Lopez, G., Valencia, A., & Tress, M. L. (2007). Firestar–prediction of functionally important residue using structural templates and alignment reliability. Nucleic Acids Research, 35, 573–577.
Thompson, M. A. (2004). ArgusLab 4.0.1. Planaria Software, LLC, Seatle, WA. http://www.arguslab.com. Accessed 1 Nov 2010.
Oda, A., Okayasu, M., Kamiyama, Y., Yoshida, T., Takahashi, O., & Matsuzaki, H. (2007). Evaluation of docking accuracy and investigation of roles of parameters and each term in scoring functions for protein-ligand docking using ArgusLab software. Bulletin Chemical Society of Japan, 80, 1920–1925.
Meagher, K. L., & Carlson, H. A. (2005). Solvation influences flap collapse in HIV-1 protease. Proteins, 58, 119–125.
Darden, T., Perera, L., Li, L., & Pedersen, L. (1999). New tricks for modelers from the crystallography toolkit: The particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure, 7, 55–60.
Lindahl, E., Hess, B., & Van der Spoel, D. (2001). GROMACS 3.0: A package for molecular simulation and trajectory analysis. Journal of Molecular Modeling, 7, 306–317.
Wang, Z., & Moult, J. (2001). SNPs, protein structure and disease. Human Mutation, 17, 263–270.
Suhre, K., & Sanejouand, Y. H. (2004). ElNemo: A normal mode web-server for protein movement analysis and the generation of templates for molecular replacement. Nucleic Acids Research, 32, 610–614.
Zacharias, M. (2004). Rapid protein–ligand docking using soft modes from molecular dynamic simulations to account for protein deformability: binding of FK506 to FKBP. Proteins, 54, 759–767.
Brunne, R. M., Berndt, K. D., Guntert, P., Wuthrich, K., & van Gunsteren, W. F. (1995). Structure and internal dynamics of the bovine pancreatic trypsin inhibitor in aqueous solution from long-time molecular dynamics simulations. Proteins, 23, 49–62.
Eyrisch, S., & Helms, V. (2007). Transient pocket on protein surface involved in protein–protein interaction. Journal of Medicinal Chemistry, 50, 3457–3464.
Acknowledgments
The authors express deep sense of gratitude to the management of Vellore Institute of Technology for all the support, assistance, and constant encouragements to carry out this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shanthi, V., Rajasekaran, R. & Ramanathan, K. Computational Identification of Significant Missense Mutations in AKT1 Gene. Cell Biochem Biophys 70, 957–965 (2014). https://doi.org/10.1007/s12013-014-0003-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0003-8